1,2,3-Triazole derivatives as highly selective cannabinoid receptor type 2 (CB2) agonists

MLA

Stephen J. Cutler, et al. “1,2,3-Triazole Derivatives as Highly Selective Cannabinoid Receptor Type 2 (CB2) Agonists.” Arabian Journal of Chemistry, vol. 15, no. 1, Jan. 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....caa62d43243126db8c9f94547658393d&authtype=sso&custid=ns315887.

APA

Stephen J. Cutler, Robert J. Doerksen, Anastassiya V. Gadetskaya, Amer H. Tarawneh, Lo’ay Al-Momani, Sultan T. Abu-Orabi, & Pankaj Pandey. (2022). 1,2,3-Triazole derivatives as highly selective cannabinoid receptor type 2 (CB2) agonists. Arabian Journal of Chemistry, 15(1).

Chicago

Stephen J. Cutler, Robert J. Doerksen, Anastassiya V. Gadetskaya, Amer H. Tarawneh, Lo’ay Al-Momani, Sultan T. Abu-Orabi, and Pankaj Pandey. 2022. “1,2,3-Triazole Derivatives as Highly Selective Cannabinoid Receptor Type 2 (CB2) Agonists.” Arabian Journal of Chemistry 15 (1). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....caa62d43243126db8c9f94547658393d&authtype=sso&custid=ns315887.